MG
LinkedIn

Maya Gosztyla, PhD

Co-Founder and Chief Scientific Officer

San Diego, California, United States · 1 connection

BrainStorm Therapeutics, Inc.

Not on Unlinked · Imported profile. Is this you? Claim it

About

Experimental and computational biologist with expertise in iPSC-derived neuronal and brain organoid models, high-throughput screening, RNA biology, and machine learning for drug discovery. My work bridges wet-lab innovation and computational analysis to accelerate therapeutic discovery for neurodegenerative and neurodevelopmental disorders. As Co-Founder and CSO at BrainStorm Therapeutics, I’ve developed organoid-based and AI-driven discovery platforms, built scalable lab operations, and secured strategic partnerships and investor interest. My career spans 15+ peer-reviewed publications, a provisional patent, and multiple competitive awards, including the NVIDIA Award at the Evolved Bio x ML Hackathon and the JPM Women’s Health Pitch Competition Audience Choice Award. Core expertise: Translational neuroscience | Stem cell culture and differentiation | Brain organoid production | High-throughput screening | Bulk and single-cell RNA-seq | Multi-omics integration | Machine learning (Scikit-learn, PyTorch) | Startup operations | Strategic partnerships | Grant writing | Scientific communication. I’m passionate about turning cutting-edge biology into actionable therapies, leveraging both

Experience

Co-Founder and Chief Scientific OfficerBrainStorm Therapeutics, Inc.
Sep 2024
VP of ImpactNucleate
Nov 2021 to Apr 2023
Post-Baccalaureate IRTA FellowNational Center for Advancing Translational Sciences (NCATS)
May 2018 to Jul 2019
Undergraduate Research FellowThe Ohio State University
Sep 2015 to Apr 2018
Summer Research FellowEPFL
Jun 2017 to Jul 2017
Summer Research InternNationwide Children's Hospital
Jun 2014 to Aug 2014

Education

UC San Diego
Doctor of Philosophy - PhD, Biomedical Sciences
2019 to 2024
The Ohio State University
Bachelor of Science - BS, Neuroscience and Molecular Genetics
2014 to 2018